anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Problem Agitate Solution

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 26,550
Current window 16,771-16,800
Pages 885
Rows per page 30
Arc: Problem Agitate Solutionclear collectionreset all
18 30 60

Arc

16,771-16,800 of 26,550

filter-aware
03
Uses a table to compare specific element concentrations (Nd, Pr, Dy, Tb) and a quote from the CEO to highlight a discrepancy.Ramaco Resources, Inc. (METC) · Wolfpack Research
Research note Short seller Beat · Villain CritiqueLoop · Zoom In1 hit
04
Includes a direct quote from the CEO to expose a contradiction regarding REE concentration levels.Ramaco Resources, Inc. (METC) · Wolfpack Research
Research note Short seller Beat · Villain CritiqueLoop · Zoom In1 hit
05
Includes two quotes from industry figures to support the argument that recoverability testing is standard and inexpensive.Ramaco Resources, Inc. (METC) · Wolfpack Research
Research note Short seller Beat · Villain CritiqueLoop · Zoom In1 hit
06
Uses quotes from Randall Atkins (METC CEO) and Rick Pobjoy (AR3 Founder) to frame the contradiction.Ramaco Resources, Inc. (METC) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
08
The slide uses a cartoonish image of a coal lump to mock the company's branding and claims.Ramaco Resources, Inc. (METC) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
09
The slide uses evidence of shared office space and overlapping business activities to link Ramaco Carbon and Ram Omni LLC.Ramaco Resources, Inc. (METC) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
01
Slide 1
This is a research note cover/summary page from Wolfpack Research.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Problem1 hit
02
This page is a continuation of a research note, focusing on specific financial liabilities and asset quality issues.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Problem1 hit
03
The slide argues that retail investors are being sold risky, unsecured debt by the company's own financial advisers.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Problem1 hit
04
The slide uses a combination of a bar chart to show cash depletion and a table to detail specific high-risk loan exposures.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Problem1 hit
05
The slide uses Bloomberg's proprietary default risk model to categorize companies into IG, HY, and DS grades, then maps specific RILY debtors against industry distributions.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · AgitateLoop · Aha Moment1 hit
06
The slide uses a narrative structure to build a case for financial distress, citing specific debt covenants and asset value declines.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · AgitateLoop · Aha Moment1 hit
07
Includes a Bloomberg stock chart for XELA showing a 99.59% decline.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · AgitateLoop · Aha Moment1 hit
08
The slide uses Bloomberg stock charts to illustrate the decline of two companies involved in complex financial arrangements with B. Riley (RILY).B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · AgitateLoop · Aha Moment1 hit
09
The slide uses a short-seller research report style to critique RILY's capital allocation and loan portfolio quality.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · AgitateLoop · Aha Moment1 hit
10
Includes a pie chart visualizing the risk profile of RILY's loan portfolio.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Agitate1 hit
11
The slide uses a narrative of 'self-harm' to describe RILY's investment strategy, framing the transaction as a circular fee-generating mechanism.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · SolutionLoop · Iceberg1 hit
12
Includes a specific table analyzing the purchase price allocation for magicJack.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · SolutionLoop · Iceberg1 hit
05
This is a page from a Citizen Petition document.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · EvidenceLoop · Cost Of Inaction1 hit
06
This is a text-heavy regulatory filing page. It uses anecdotal evidence from prescriber interviews and social media to argue that current warnings are insufficient.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · EvidenceLoop · Cost Of Inaction1 hit
07
The slide serves as a foundational disclosure for a regulatory filing, establishing the credibility and scope of the petitioner's investigative work.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · Executive Summary1 hit
08
This appears to be a page from a legal or regulatory petition (Citizen Petition) detailing allegations against a drug product.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · Appendix Disclosure1 hit
09
This is a standard legal/regulatory filing signature page.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · Appendix Disclosure1 hit
01
Slide 1
This is a regulatory filing document (Citizen Petition) formatted as a letter.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Attention1 hit
02
This is a text-heavy regulatory filing document, likely part of a petition to the FDA regarding safety concerns.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Problem & Complication1 hit
03
This appears to be a page from a regulatory filing or activist short report, focusing on adverse event reporting and potential obfuscation by the manufacturer.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Problem & Complication1 hit
05
The slide is a text-heavy regulatory filing page, likely part of a petition or formal complaint. It uses numbered points to build a case of scientific misconduct.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Problem & Complication1 hit
06
This appears to be a page from an activist short report or regulatory challenge document.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Desire1 hit
07
This slide functions as a legal/regulatory petition document, outlining specific grievances regarding trial design, data integrity, and patient safety.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Solution & Approach1 hit
08
This is a text-heavy regulatory document page.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Solution & Approach1 hit